Rubra Medicaments Limited (531099) Soars 3.72% on Feb 14

February 14, 2018 - By Adrian Erickson

Shares of Rubra Medicaments Limited (BOM:531099) last traded at 5.85, representing a move of 3.72%, or 0.21 per share, on volume of 1,950 shares. After opening the trading day at 5.84, shares of Rubra Medicaments Limited traded in a close range. Rubra Medicaments Limited currently has a total float of 5.47M shares and on average sees 1,364 shares exchange hands each day. The stock now has a 52-week low of 4.52 and high of 6.3.

BSE & NSE: Driving Indian Economy

The Bombay Stock Exchange (BSE) and the National Stock Exchange of India (NSE), the two primary stock exchanges in India representing 4% of the national gross domestic product (GDP), are among the world’s fastest growing and highly anticipated stock exchanges. This indicates that India is a thriving nation that will soon become one of Asia’s best assets.

The 1st Asian Stock Exchange

Established in 1875, the BSE is the first ever stock exchange in India and in Asia. In India, it is the first entity to acquire permanent acknowledgement under the Securities Contract Regulation Act of 1956.

More than a hundred years following its foundation, the BSE is now recognized as the 11th largest stock exchange in the world. The BSE has a market valuation of $1.70 trillion as of January 23, 2015. Moreover, it is also one of the fastest stock exchanges in the world, boasting with a six-microsecond speed.

Measuring the 30 most active stocks on the BSE is the SENSEX 30, which has a base value of 100 with its base date being 1978 to 1979. Companies are tracked based on certain factors such as depth, liquidity, market capitalization, among others.

On July 25, 1990, the BSE first recorded a four-digit figure. When the Bhartiya Janta Party won in the General Elections, the BSE first recorded a 5,000 figure on October 11, 1999. On February 6, 2006, it first recorded a 10,000 figure. On December 11, 2007, it first recorded a 20,000 figure. On March 4, 2015, it first recorded a 30,000 figure.

However, the BSE is not all about those feats. Like any other stock exchanges, it also had its worst days.

In January 2008, the BSE had recorded its biggest fall, losing over 2,000 points in just two consecutive sessions. In August 2015, it had also recorded a huge one-day decline, dropping more than 1,700 points after the Chinese equity market had fallen almost 9%. China is the biggest Asian economy, which is why all Asian markets also suffered from its own downturn. Rubra Medicaments Limited is a stock traded on the Indian stock exchange.

The 1st Electronic Indian Stock Exchange

Founded in 1992, the NSE also takes pride in being a ‘first” it is the first stock exchange in India with electronic capabilities. Currently, Indian Index Services and Products (IISP) own and operate it, supporting roughly 230,000 terminals throughout the country.

Weighing the 50 most active stocks on the NSE is the NIFTY, which has a base value of 1,000 with its base date being 1995. Like BSE stocks, NSE stocks are also measured based on different factors such as market capitalization. Rubra Medicaments Limited has relatively good liquidity.

The NIFTY represents a broader aspect of the corporate sector of India than the SENSEX 30. Regardless, both indices are reliable indicators of the whole Indian economy and national growth prospects as well.

The Asian economy is full of promising potentials. With India being one of the drivers pushing it to the global footprint, it is only reasonable to invest in BSE and NSE stocks today. Professional analysts might be interested how this will affect Rubra Medicaments Limited.

Another recent and important Rubra Medicaments Limited (BOM:531099) news was published by Economictimes.Indiatimes.com which published an article titled: “India’s most profitable! 47 firms that saw QoQ profit growth in last 1 year” on May 26, 2016.

Rubra Medicaments Limited engages in the trading of pharmaceuticals, and other medical and surgical products. The company has market cap of $31.99 million. The firm was incorporated in 1991 and is based in Mumbai, India. It has a 34.21 P/E ratio.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: